Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Cardio Diagnostics Holdings Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cardio Diagnostics Holdings Inc. December 18, 202393.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2024 | Cardio Diagnostics Holdings Inc. | Option exercise | +8,803 | $1.42 | $12,500 |
| Jan 31, 2024 | Cardio Diagnostics Holdings Inc. | Option exercise | +917 | $2.18 | $1,999 |
| Dec 31, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +1,606 | $2.49 | $3,999 |
| Dec 31, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +5,020 | $2.49 | $12,500 |
| Oct 31, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +6,631 | $0.30 | $1,989 |
| Sep 30, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +5,882 | $0.34 | $2,000 |
| Sep 30, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +36,765 | $0.34 | $12,500 |
| Aug 31, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +3,637 | $0.55 | $2,000 |
| Jul 31, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +1,653 | $1.21 | $2,000 |
| Jul 1, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +8,403 | $1.19 | $10,000 |
| Jun 30, 2023 | Cardio Diagnostics Holdings Inc. | Option exercise | +21,008 | $1.19 | $25,000 |
Questions about Stanley K. Lau
What boards is Stanley K. Lau on?
Stanley K. Lau sits on the board of Cardio Diagnostics Holdings Inc.
How long has Stanley K. Lau served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.